文献速递消化道肿瘤与早癌消化内镜

葡萄牙北部基于FIT的结直肠癌筛查项目对早期诊断与短期生存的影响

An Organized Fecal Immunochemical Test-Based Screening Program Affects Colorectal Cancer Early Diagnosis and Survival in the Short Term.
PubMed 文献 · Am J Gastroenterol · 2025-10-13

该研究评估了葡萄牙北部2018年引入的两年一次FIT筛查项目对结直肠癌早期诊断和生存的影响。2018-2020年发送482,938份邀请,依从率34.4%,FIT阴性预测值99.95%;接受FIT或结肠镜者早期癌比例和净生存率显著高于未筛查者。

要点

  • FIT筛查依从率34.4%,总体覆盖率为44.9%
  • 接受FIT或结肠镜者早期癌比例显著高于未筛查者
  • FIT或结肠镜筛查者1年和3年净生存率显著更高

核心结论

  • 两年一次FIT筛查在引入短期即可提高早期诊断率并改善生存,优于不筛查。

研究设计与样本

  • 基于葡萄牙北部人群的回顾性队列研究。
  • 数据来自葡萄牙国家癌症登记处2014-2020年确诊的结直肠癌病例。
  • 2018-2020年筛查数据与北部地区卫生管理局FIT筛查项目链接。

主要发现

  • 2018-2020年共发送482,938份FIT筛查邀请,依从率为34.4%(165,895人)。
  • FIT阴性预测值为99.95%(95% CI: 99.94-99.96)。
  • FIT和/或结肠镜总体覆盖率为44.9%。
  • 接受FIT筛查者早期癌比例为58.3%,接受结肠镜者为62.8%,未筛查者为49.2%(P < 0.001)。
  • 接受FIT或结肠镜者1年和3年净生存率显著高于未筛查者(P < 0.001)。

临床怎么用

  • 两年一次FIT筛查可作为提高结直肠癌早期诊断和短期生存的筛查策略。
  • 包含FIT替代方案的筛查项目可能提高人群覆盖率和结直肠癌结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In 2018, a biennial fecal immunochemical test (FIT) screening program for colorectal cancer (CRC) was introduced in northern Portugal, targeting 1.1 million residents aged 50-74 years. The aim of this study was to evaluate trends in CRC incidence, early diagnosis, and survival before and after the program's implementation. METHODS: This was a population-based retrospective cohort study in northern Portugal. Data on CRC cases diagnosed between 2014 and 2020 were retrieved from the Portuguese National Cancer Registry. Early diagnosis was defined as stage I/II tumors. Net survival estimates for 2014-2016 vs 2018-2020 were compared. Data from Portuguese National Cancer Registry were linked to the FIT-based screening program of the Northern Portugal Regional Health Administration for the years 2018-2020 to assess screening outcomes. RESULTS: Between 2018 and 2020, the first 3 years of the program, 482,938 invitations for FIT screening were sent, resulting in an adherence rate of 34.4% (165,895). The negative predictive value of FIT was 99.95% (95% CI: 99.94-99.96). Overall, coverage by FIT and/or colonoscopy was 44.9%. The proportion of early cancers was significantly higher among individuals who accepted FIT screening (58.3%) or underwent colonoscopy (62.8%) compared with unscreened individuals (49.2%) ( P < 0.001). Net survival rates at 1 year and 3 years were significantly higher among individuals who accepted FIT screening or underwent colonoscopy compared with those who remained unscreened ( P < 0.001). DISCUSSION: Biennial FIT led to an increase in early diagnoses and improved survival, compared with no screening, in the short term after its introduction. A screening program that includes alternatives to FIT may increase population coverage and improve CRC outcomes.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Silva JC, Leite-Silva P, Tavares F, et al. An Organized Fecal Immunochemical Test-Based Screening Program Affects Colorectal Cancer Early Diagnosis and Survival in the Short Term. Am J Gastroenterol. 2025. PMID: 41081565. doi:10.14309/ajg.0000000000003797

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。